BTK Inhibitors and the Genomic Shift in CLL

Moderated by Tycel Phillips, MD, of City of Hope National Medical Center, a panel of experts discuss the evolving genomic and therapeutic landscape of chronic lymphocytic leukemia (CLL) during a Blood Cancers Today Roundtable. The discussion features Seema Bhat, MD, of The Ohio State University; Erin Mulvey, MD, of Weill Cornell Medicine; Danielle Brander, MD, of Duke Cancer Institute; and Andres Chang, MD, PhD, of the Winship Cancer Institute at Emory University. Watch more like this at www.bloodcancerstoday.com